The Light Microscopy Core Facility (LMCF) at Duke serves as the Light Microscopy Shared Resource for the Duke Cancer Institute (DCI). The facility offers affordable and efficient access to more than $6 million of confocal and conventional fluorescence microscopes and image analysis resources to all members of the University and the Medical Center. Dedicated staff provides training and full technical support for all the instruments; DCI members receive priority for training. Trained users can access the equipment 24 hours a day. The LMCF is funded by the DCI (including the CCSG), the Duke University School of Medicine, the Duke University Office of the Provost, the National Institutes of Health, and the North Carolina Biotechnology Center, in addition to user fees. The LMCF provides access to confocals (eight), live cell fluorescence microscopes, spinning disk, multiphoton, TIRF and more to allow fluorescence imaging of samples ranging from fixed immunofluorescence slides and live cell tissue culture models, to model organisms and intravital imaging of mice. Essentially all standard optical sectioning and microscopy methods are present - confocal, resonant scanning confocal, spinning disk, live cell imaging with several modalities, long-term incubated time-lapse, multiphoton including with scale-cleared samples allowing imaging up to 8 mm into the sample, photoactivation/photoconversion and photokinetic (FRAP, FLIP) capabilities, time-correlated single-photon counting fluorescence lifetime imaging and a broad range of analysis capabilities are available, with training and assistance, to all users. The shared resource's three full-time PhD-level staff members provide assistance with all aspects of imaging, including processing and quantitative analysis of images. From 2009 through 2013, LMCF was used by over 1,200 people (over 2,200 trainings) from over 360 labs for over 106,000 hours of imaging over 41,000 sessions. In 2012 LMCF was used 10,611 times by 223 labs for 28,622 hours of imaging and analysis. In 2012, 96 of the 223 labs (43%) were from the DCI; of those, 82 (85%) had peer-reviewed funding and 14 (15%) did not. 226 publications from DCI members resulted from LMCF usage during the funding period. LMCF's DCI users represent all nine CCSG-recognized Research Programs. Booking is done on a first-come, first-served basis with some limits to promote efficient use. The significant number of machines in the facility provides good capacity, availability of the machines is good, and bottlenecks are generally few and temporary. In recognition of the CCSG-contribution, DCI members are prioritized for training and assistance. The facility's ongoing priority is continued support of the users and systems for continued productivity, with acquisition and implementation of new technologies if they prove valuable.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-43
Application #
9198498
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-01-01
Budget End
2017-12-31
Support Year
43
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Duan, Bensong; Hu, Jiangfeng; Liu, Hongliang et al. (2018) Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. Int J Cancer 142:1322-1331
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031
Wen, Juyi; Liu, Hongliang; Wang, Lili et al. (2018) Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. J Thorac Oncol 13:660-675
Li, Bo; Wang, Yanru; Xu, Yinghui et al. (2018) Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer 142:2303-2312
Gearhart-Serna, Larisa M; Jayasundara, Nishad; Tacam Jr, Moises et al. (2018) Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations. J Environ Public Health 2018:5610462
Bakthavatsalam, Subha; Sleeper, Mark L; Dharani, Azim et al. (2018) Leveraging ?-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells. Angew Chem Int Ed Engl 57:12780-12784

Showing the most recent 10 out of 513 publications